Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
35 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2020-01-30 | 2020-03-12 | 104896 |
TEVA-ERLOTINIB | 150MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176830 |
TEVA-ERLOTINIB | 25MG | TABLET | Actual shortage | 2024-06-07 | 2024-06-07 | 229957 |
TEVA-ERLOTINIB | 100MG | TABLET | Actual shortage | 2024-06-07 | 2024-06-07 | 229960 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-03-13 | 2018-12-07 | 42562 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-02-13 | 2020-03-12 | 106008 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-19 | 106928 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-12 | 106948 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-03-26 | 2020-06-18 | 109598 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110688 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-04-16 | 2020-06-18 | 112379 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-07-09 | 2021-02-05 | 119877 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-08-20 | 2020-09-24 | 122717 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-18 | 2021-03-18 | 134349 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-08 | 170779 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2022-09-30 | 2022-12-02 | 170798 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179183 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180906 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-08 | 2023-06-27 | 194141 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195133 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
ACT DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
ACT DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
ACT DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
ACT DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |